Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Baumann

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
Pharmacopsychiatry|July 3, 2026
A Tribute to Prof. Jules Angst highlighting his Contributions to ClozapineGeorgios Schoretsanitis, Michael Bauer, Pierre Baumann, et al.
Journal of Clinical Psychopharmacology|August 29, 2012
Multicenter study on the clinical effectiveness, pharmacokinetics, and pharmacogenetics of mirtazapine in depressionEveline Jaquenoud Sirot, Sabine Harenberg, Pierre Vandel, et al.
The Lancet. Oncology|October 1, 2020
Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trialPaul Sargos, Sylvie Chabaud, Igor Latorzeff, et al.
Breast (Edinburgh, Scotland)|September 28, 2014
Radiotherapy associated with concurrent bevacizumab in patients with non-metastatic breast cancerVictor Pernin, Lisa Belin, Paul Cottu, et al.
The Lancet. Psychiatry|March 1, 2025
Efficacy of clozapine versus second-generation antipsychotics in people with treatment-resistant schizophrenia: a systematic review and individual patient data meta-analysisJohannes Schneider-Thoma, Tasnim Hamza, Konstantina Chalkou, et al.
The International Journal of Neuropsychopharmacology|March 8, 2008
Antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidenceNorman Sartorius, Thomas C Baghai, David S Baldwin, et al.
The Journal of Clinical Psychiatry|May 21, 2020
Blood Levels to Optimize Antipsychotic Treatment in Clinical Practice: A Joint Consensus Statement of the American Society of Clinical Psychopharmacology and the Therapeutic Drug Monitoring Task Force of the Arbeitsgemeinschaft für Neuropsychopharmakologie und PharmakopsychiatrieGeorgios Schoretsanitis, John M Kane, Christoph U Correll, et al.
Der Nervenarzt|July 17, 2019
[Erratum to: Therapeutic drug monitoring in neuropsychopharmacology : Summary of the consensus guidelines 2017 of the TDM task force of the AGNP]Stefan Unterecker, Gudrun Hefner, Pierre Baumann, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|March 2, 2018
TDM in psychiatry and neurology: A comprehensive summary of the consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology, update 2017; a tool for clinicians<sup/>Georgios Schoretsanitis, Michael Paulzen, Stefan Unterecker, et al.
Der Nervenarzt|November 18, 2018
[Therapeutic drug monitoring in neuropsychopharmacology : Summary of the consensus guidelines 2017 of the TDM task force of the AGNP]Stefan Unterecker, Gudrun Hefner, Pierre Baumann, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Pharmacopsychiatry|July 3, 2026
A Tribute to Prof. Jules Angst highlighting his Contributions to ClozapineGeorgios Schoretsanitis, Michael Bauer, Pierre Baumann, et al.
Journal of Clinical Psychopharmacology|August 29, 2012
Multicenter study on the clinical effectiveness, pharmacokinetics, and pharmacogenetics of mirtazapine in depressionEveline Jaquenoud Sirot, Sabine Harenberg, Pierre Vandel, et al.
The Lancet. Oncology|October 1, 2020
Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trialPaul Sargos, Sylvie Chabaud, Igor Latorzeff, et al.
Breast (Edinburgh, Scotland)|September 28, 2014
Radiotherapy associated with concurrent bevacizumab in patients with non-metastatic breast cancerVictor Pernin, Lisa Belin, Paul Cottu, et al.
The Lancet. Psychiatry|March 1, 2025
Efficacy of clozapine versus second-generation antipsychotics in people with treatment-resistant schizophrenia: a systematic review and individual patient data meta-analysisJohannes Schneider-Thoma, Tasnim Hamza, Konstantina Chalkou, et al.
The International Journal of Neuropsychopharmacology|March 8, 2008
Antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidenceNorman Sartorius, Thomas C Baghai, David S Baldwin, et al.
The Journal of Clinical Psychiatry|May 21, 2020
Blood Levels to Optimize Antipsychotic Treatment in Clinical Practice: A Joint Consensus Statement of the American Society of Clinical Psychopharmacology and the Therapeutic Drug Monitoring Task Force of the Arbeitsgemeinschaft für Neuropsychopharmakologie und PharmakopsychiatrieGeorgios Schoretsanitis, John M Kane, Christoph U Correll, et al.
Der Nervenarzt|July 17, 2019
[Erratum to: Therapeutic drug monitoring in neuropsychopharmacology : Summary of the consensus guidelines 2017 of the TDM task force of the AGNP]Stefan Unterecker, Gudrun Hefner, Pierre Baumann, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|March 2, 2018
TDM in psychiatry and neurology: A comprehensive summary of the consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology, update 2017; a tool for clinicians<sup/>Georgios Schoretsanitis, Michael Paulzen, Stefan Unterecker, et al.
Der Nervenarzt|November 18, 2018
[Therapeutic drug monitoring in neuropsychopharmacology : Summary of the consensus guidelines 2017 of the TDM task force of the AGNP]Stefan Unterecker, Gudrun Hefner, Pierre Baumann, et al.
Pageof 10